Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Ad... Read More

Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant... Read More

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More

"Teachers' rights are bigger than political differences": Former Goa Congress chief Amit Patkar

North Goa, Sept. 6 -- Former Goa Pradesh Congress Committee president Amit Patkar on Sunday launched a sharp attack on the BJP Government over the continuing insecurity faced by Goa's teaching communi... Read More

NHRC, enforced disappearance bills passed amid opposition walkout

Sangsad Bhaban, Sept. 6 -- Parliament on Sunday passed three bills, including two important ones -- the National Human Rights Commission Bill, 2026 and the Enforced Disappearance Prevention and Redres... Read More

AIIMS-Jammu to be 1st hospital in country to get CISF cover

New Delhi, Sept. 6 -- The All India Institute of Medical Sciences (AIIMS) in Jammu could become the first hospital in the country to be guarded by an armed contingent of the CISF given its "sensitive"... Read More

Srinagar MP accuses J&K govt of coercing interns to end stir

Srinagar, Sept. 6 -- Member of Parliament and National Conference leader Aga Ruhullah Mehdi on Sunday criticised the Jammu and Kashmir administration over the handling of the ongoing protest by medica... Read More

People will never accept CPI(M) again: Tripura CM Saha

Agartala, Sept. 6 -- Tripura Chief Minister Manik Saha on Sunday said that the Opposition has no basic knowledge of politics, and their politics only revolves around confusing the public. Saha said t... Read More

• ««
• «
• 1721
• 1722
• 1723
• 1724
• 1725
• 1726
• 1727
• 1728
• 1729
• 1730
• »
• »»